Acute pulmonary embolism caused by highly aggregated intravenous immunoglobulin-Reference-Cited by-同舟云学术

Acute pulmonary embolism caused by highly aggregated intravenous immunoglobulin

Published:2015-07-21 Issue:1 Volume:110 Page:27-35
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Yu C. F.¹,Hou J. F.¹,Shen L. Z.¹,Gao K.¹,Rao C. M.¹,Yang P. Y.¹,Fu Z. H.¹,Wang Q. Z.¹,Li Y. H.¹,Wang L.¹,Liu F.¹,Zhang L.¹,Qu Z.¹,Shen Q.¹,Li B.¹,Li X. G.²,Wang J. Z.¹

Affiliation:

1. National Institutes for Food and Drug Control; Beijing China

2. Centre for Vaccine Evaluation; Biologics and Genetic Therapies Directorate; HPFB, Health Canada; Ottawa ON Canada

Funder

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12307/fullpdf

Reference32 articles.

1. Intravenous immunoglobulins: evolution of commercial IVIG preparations;Hooper;Immunol Allergy Clin North Am,2008

2. Clinical applications of intravenous immunoglobulins (IVIg)-beyond immunodeficiencies and neurology;Hartung;Clin Exp Immunol,2009

3. Intravenous immune globulins: an update for clinicians;Knezevic-Maramica;Transfusion,2003

4. Adverse effects of human immunoglobulin therapy;Stiehm;Transfus Med Rev,2013

5. Safety of intravenous immunoglobulin treatment;Caress;Expert Opin Drug Saf,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments;2024-04-26

2. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events—a case series and review of the literature;Immunologic Research;2018-12

3. Blood, Blood Components, Plasma, and Plasma Products;Side Effects of Drugs Annual;2017

4. Immune globulin;Reactions Weekly;2016-04

5. Blood, Blood Components, Plasma, and Plasma Products;Side Effects of Drugs Annual;2016